Welcome to Word Press
This video is basically for the beginners who want to learn Word Press. It is just introductory tutorial. In my other tutorials i explain more.
By: Tariq Umair
See the original post:
Welcome to Word Press - Video
DGAP-News: WILEX AG / Key word(s): Agreement WILEX AG regains US rights for RENCAREX(R) from Prometheus
07.11.2013 / 07:25
=--------------------------------------------------------------------
PRESS RELEASE
WILEX regains US rights for RENCAREX(R) from Prometheus
Munich, Germany, 07 November 2013. WILEX AG (ISIN DE0006614720/ WL6 / FSE) and Prometheus Laboratories Inc. (Prometheus), San Diego, CA, USA, agreed as of 31 October 2013 on the terms of the termination of the 2011 license agreement on RENCAREX(R) (Girentuximab). As announced on 3 June 2013, Prometheus and WILEX decided to finalise the cooperation and to discuss the formalities and timing regarding the termination.
According to the settlement agreement, WILEX regains the US commercialisation rights for RENCAREX(R) and will receive a final payment of USD 1.75 million covering Prometheus' obligations under the collaboration agreement for the RENCAREX(R) development costs. Prometheus will no longer participate in the RENCAREX(R) development. The parties have no further mutual obligations.
WILEX has received upfront and milestone payments of USD 39 million plus 40% of development costs since the beginning of the collaboration.
RENCAREX(R) is a Phase III product candidate for adjuvant therapy of non-metastatic clear cell Renal Cell Carcinomas (ccRCC). In October 2012, the Phase III ARISER trial failed to meet its primary endpoint. The final analysis showed no improvement in median disease-free survival following treatment with RENCAREX(R) compared to placebo. However, WILEX carried out an extensive subgroup and biomarker analysis and presented positive subgroup data at the ASCO Annual Meeting in June 2013. The results of this retrospective analysis showed that RENCAREX(R) has a therapeutic effect in the subgroup of patients with a high score of the antigen CAIX. Disease-free survival in this group showed a clinically and statistically significant improvement compared to both placebo and patients with a low CAIX score.
Professor Olaf G. Wilhelm, CEO of WILEX AG, commented: 'We look back on a very valuable collaboration with Prometheus. Due to the top line data of RENCAREX(R) and the delay of a marketable product, Prometheus' request to terminate was not a surprise to us. We are delighted that we came to an agreement that works for both parties. The return of the US rights for RENCAREX(R) offers us new and broader options for its commercialisation.'
Visit link:
PRESS RELEASE: WILEX AG regains US rights for RENCAREX(R) from Prometheus
DGAP-News: Tipp24 SE / Key word(s): Quarter Results Tipp24 SE: Further success for Tipp24 SE in third quarter
06.11.2013 / 09:07
=--------------------------------------------------------------------
Press release
Report on the first nine months of 2013
Further success for Tipp24 SE in third quarter - relocation to London progressing as planned
- Revenue of EUR 104.4 million - adjusted EUR 97.9 million - at prior-year level
- EBIT of EUR 26.2 million - adjusted EUR 24.3 million
- Guidance confirmed
(Hamburg, 6 November 2013) Tipp24 SE continued its successful development in the third quarter of 2013. Consolidated revenue of EUR 104.4 million in the first nine months was on a par with the previous year (EUR 105.1) million. The adjusted figure amounted to EUR 97.9 million, compared to EUR 95.8 million in the previous year. Although consolidated EBIT fell to EUR 26.2 million, after EUR 47.5 million in the previous year, adjusted EBIT reached EUR 24.3 (25.4) million with an EBIT margin of 24.8 percent, compared to 26.5 percent in the previous year.
Original post:
PRESS RELEASE: Tipp24 SE: Further success for Tipp24 SE in third quarter
DGAP-News: 4SC AG / Key word(s): Quarter Results/Miscellaneous Press Release: 4SC announces improved financial results for the third quarter and first nine months of 2013
07.11.2013 / 07:31
---------------------------------------------------------------------
Press Release
4SC announces improved financial results for the third quarter and first nine months of 2013
Planegg-Martinsried, Germany, 7 November 2013 - 4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer and autoimmune diseases, today announced the financial results for the 4SC Group in accordance with International Financial Reporting Standards (IFRS) for the third quarter and first nine months of 2013.
Operating highlights in Q3 (1 July - 30 September 2013):
- Resminostat: Expression of ZFP64 biomarker and other patient characteristics strongly correlate with patient survival in liver cancer (HCC) and Hodgkin's lymphoma; study results presented at ILCA (Washington) and ECCO (Amsterdam) research conferences
- Resminostat: Partner Yakult Honsha starts clinical development in non-small-cell lung cancer (NSCLC) in Japan, making this the fourth tumour indication
- 4SC-202: Patent protection in China, Hong Kong and the USA expanded significantly
See more here:
DGAP-News: Press Release: 4SC announces improved financial results for the third quarter and first nine months of 2013
The Associated Press This March 22, 2013, file photo shows the setting sun reflected in the windows of the U.S. Capitol in Washington. If theres one word that describes how Americans feel about politics these days, its negative. Majorities disapprove of Congress and the president and say the nation is heading in the wrong direction. Few trust their political leaders to make the right decisions, and some polls suggest voters would like to see the whole lot turned out next November. (AP Photo/Alex Brandon)
By JENNIFER AGIESTA/Associated Press/November 7, 2013
If theres one word that describes how Americans feel about politics these days, its negative. Majorities disapprove of Congress and the president and say the nation is heading in the wrong direction. Few trust their political leaders to make the right decisions, and some polls suggest voters would like to see the whole lot turned out next November.
Yet an Associated Press-GfK poll in October found more people tuning in to politics warts and all than tuning out.
Its not a major election year, so day-to-day interest in following news about politics and elections was lower than at the height of last years presidential campaign. But just 11 percent said theyre less interested in politics today than four years ago, while 30 percent said theyre more interested than in 2009, before the birth of the tea party or the passage of the health insurance overhaul, when people were about twice as likely as they are now to say the country was heading in the right direction.
Although those who are increasingly attentive to politics now are more likely to identify with a political party than as political independents, they seem to buck a notable trend in Washington: Rather than reflecting the increasing polarization seen in Congress, they tend to mirror the positions of the overall American public. The poll suggests those paying more attention to politics these days hold similar views to Americans generally on a range of prominent issues: the health overhaul law, gun laws, illegal immigration, abortion, same-sex marriage and the seriousness of climate change.
Tuesdays elections in New Jersey and Virginia also suggested a win for the ideological middle. According to exit polls conducted for The Associated Press, Virginia voters broadly rejected Republican Ken Cuccinelli as too conservative, and GOP Gov. Chris Christie trampled Democratic nominee Barbara Buono despite 57 percent of his states voters holding a negative impression of his party.
Those tuning out are less likely to see big differences between what the Democrats and Republicans stand for, a position that may reflect judgments about politicians motivations rather than their policies.
They frequently cite negativity in politics rather than specific positions as a reason for their distaste. One poll respondent said, The Republicans are acting like babies. The Democrats are acting like babies. Its unsettling and disgusting. Another, I get tired of hearing the bickering, and I dont trust anything any of the politicians say.
The AP-GfK Poll was conducted Oct. 3-7, 2013, and involved online interviews with 1,227 adults. The survey has a margin of sampling error of plus or minus 3.4 percentage points for all respondents.
Go here to read the rest:
DIGITS: Fed up, but not tuning out